Ashfaque A Memon Selected Research

methylallyl trisulfide (MATS)

9/2021	The Association between Blood-Based Global DNA Methylation and Venous Thromboembolism.
2/2019	Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.
1/2019	Association of recurrent venous thromboembolism and circulating microRNAs.
8/2018	Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.
3/2018	Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.
10/2014	Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.
3/2014	Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ashfaque A Memon Research Topics

Disease

12	Venous Thromboembolism 07/2021 - 03/2014
10	Thrombophilia 09/2021 - 03/2014
6	Type 2 Diabetes Mellitus (MODY) 01/2022 - 11/2013
6	Neoplasms (Cancer) 07/2021 - 02/2009
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2015
4	Abdominal Aortic Aneurysm 05/2022 - 01/2020
4	Mental Disorders (Mental Disorder) 01/2022 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2021
3	Adjustment Disorders (Adjustment Disorder) 10/2021 - 01/2017
3	Obesity 03/2018 - 01/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 02/2018 - 01/2005
3	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 10/2015
2	Stroke (Strokes) 01/2022 - 07/2021
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 07/2021
2	Glucose Intolerance 01/2021 - 05/2015
2	Inflammation (Inflammations) 01/2020 - 07/2017
2	Insulin Resistance 05/2015 - 11/2013
2	Atherosclerosis 10/2014 - 03/2014
1	Peripheral Arterial Disease 05/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Substance-Related Disorders (Drug Abuse) 01/2022
1	Breast Neoplasms (Breast Cancer) 07/2021
1	Vascular Diseases (Vascular Disease) 12/2020
1	Aneurysm (Aneurysms) 12/2020
1	Hematologic Neoplasms (Hematological Malignancy) 09/2017
1	Chronic Disease (Chronic Diseases) 09/2017
1	Rheumatoid Arthritis 10/2015
1	Thrombosis (Thrombus) 10/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2015
1	Atypical Hemolytic Uremic Syndrome 10/2015
1	Hypertension (High Blood Pressure) 08/2015
1	Hyperglycemia 05/2015
1	Pathologic Processes 01/2015
1	Prediabetic State (Prediabetes) 01/2014
1	Fever (Fevers) 11/2013
1	Necrosis 11/2013
1	Lung Neoplasms (Lung Cancer) 02/2009

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 05/2022 - 01/2015
9	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2017
7	methylallyl trisulfide (MATS)IBA 09/2021 - 03/2014
6	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2005
5	AnticoagulantsIBA 07/2021 - 03/2014
4	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2020
3	Apolipoproteins MIBA 04/2018 - 03/2014
3	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 11/2013
2	ErbB Receptors (EGF Receptor)IBA 02/2018 - 02/2009
2	fibrin fragment D (D-dimer)IBA 01/2018 - 01/2016
2	ThrombomodulinIBA 05/2017 - 07/2016
2	LeptinIBA 05/2016 - 01/2015
1	zonulinIBA 01/2022
1	Amino Acids FDA Link 12/2020
1	HomocysteineIBA 12/2020
1	Biological ProductsIBA 12/2020
1	Peroxidase (Myeloperoxidase)IBA 01/2020
1	HDL LipoproteinsIBA 01/2020
1	Cystatin BIBA 01/2020
1	Growth Differentiation Factor 15IBA 01/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2020
1	Protein C InhibitorIBA 01/2018
1	Protein CIBA 01/2018
1	Toll-Like Receptor 9IBA 07/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	AutoantibodiesIBA 10/2015
1	Complement Factor H (Factor H)IBA 10/2015
1	Triglycerides (Triacylglycerol)IBA 05/2015
1	C-PeptideIBA 05/2015
1	C-Reactive ProteinIBA 05/2015
1	Insulin (Novolin)FDA Link 05/2015
1	human ERBB2 proteinIBA 05/2015
1	LipidsIBA 05/2015
1	Leptin ReceptorsIBA 01/2015
1	Dihydrotachysterol (AT 10)IBA 01/2015
1	Glutens (Glutelin)IBA 01/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2014
1	Interleukin-13IBA 11/2013
1	InterleukinsIBA 11/2013
1	Interleukin-2 (IL2)IBA 11/2013
1	InterferonsIBA 11/2013
1	Interleukin-12 (IL 12)IBA 11/2013
1	Interleukin-10 (Interleukin 10)IBA 11/2013
1	CytokinesIBA 11/2013
1	Interleukin-6 (Interleukin 6)IBA 11/2013
1	Interleukin-5 (Interleukin 5)IBA 11/2013
1	Interleukin-4 (Interleukin 4)IBA 11/2013
1	CalciumIBA 02/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2009
1	thiazolyl blueIBA 02/2009
1	Pharmaceutical PreparationsIBA 02/2009
1	PeroxiredoxinsIBA 01/2005
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2005
1	ProteomeIBA 01/2005
1	NADP (NADPH)IBA 01/2005

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2017